Home Novartis AG wins approval to buy GSK cancer drugs with conditions
 

Keywords :   


Novartis AG wins approval to buy GSK cancer drugs with conditions

2015-02-23 19:12:54| Biotech - Topix.net

Novartis AG has won U.S. antitrust approval to buy GlaxoSmithKline's oncology drugs, with conditions, the U.S. Federal Trade Commission said on Monday. To win U.S. approval for the $16 billion deal, Novartis agreed to divest assets related to its BRAF and MEK inhibitor drugs, now in development to fight melanoma, the FTC said.

Tags: with conditions buy approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Mortgage rates hitting affordability - Nationwide
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 10A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Storm Chris Graphics
01.07Tropical Storm Chris Public Advisory Number 2A
01.07Atlantic Tropical Weather Outlook
01.07Eastern North Pacific Tropical Weather Outlook
More »